Latest News articles

More news articles

Sign-up benefits

Unlimited site access

Newswire

Sign up to receive a newswire from medicalphysicsweb and get the latest research and industry news delivered directly to your desk.

Free company listing

List your company on medicalphysicsweb free of charge, or become a Corporate Partner and take advantage of the enhanced benefits that this status offers. Make sure that potential customers can find the products that you sell.

Post your new products online

If you have a new product to promote and you want to tell people about it, post it on medicalphysicsweb. List your product free of charge or upgrade to Star Product status and benefit from guaranteed homepage exposure for one week.

Have your say

Sign up and get the opportunity to comment on our stories. We are always interested in your opinion and will be looking for your feedback.

Running an event?

Our events listing is free so, if you are organizing an event, post it on medicalphysicsweb.

Corporate partners

For maximum exposure, become a Corporate partner. Contact our sales team.

Buyer’s Guide

Research

Jul 7, 2009

Optical spectroscopy identifies responders

Diffuse optical spectroscopy (DOS) has the potential to predict treatment response in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer. Pilot studies have raised hopes that DOS could show quickly whether this strategy of shrinking tumours prior to surgery is working. An early alert could spare patients the discomfort of unnecessary chemotherapy, as well as reduce needless delays before surgery. It could also provide encouragement to patients whose drug therapy is working that the side effects are worth tolerating.

We hope you've enjoyed the short summary of this article. To continue reading, and for unlimited access to all content on this site you will need to complete a short sign-up process. It's free of charge, and will only take a couple of minutes of your time. If you've signed up before, simply sign in below.